Trident Lifeline Limited announced a reduction in its shareholding within its subsidiary, Trident Mediquip Limited, to 58.84% following a private placement of equity shares to other shareholders. The disclosure, made to the exchange on June 9, 2026, under Regulation 30 of the SEBI (LODR) Regulations, 2015, highlights a dilution of the parent company's stake from a previous holding of 59.17%. This adjustment impacts the control structure of the subsidiary, which operates within the medical device industry.

The private placement transaction involved related parties, including Mr. Amit Bhupendra Halvawala and Mr. Chetan Chandrakant Jariwala, who are members of the promoter group and board of Trident Lifeline Limited. Despite these connections, the company confirmed that the transaction was conducted on an arm's length basis. The subsidiary, incorporated on October 19, 2019, is based in Surat, Gujarat, and specializes in the medical device sector.

Financial details provided in the filing indicate that Trident Mediquip Limited has an authorized share capital of ₹10,00,00,000 divided into 1,00,00,000 equity shares of ₹10 each. The paid-up share capital stands at ₹9,97,00,000 divided into 99,70,000 equity shares of ₹10 each. The company reported a turnover of ₹27.31 Cr for the financial year 2025-26, showing growth from ₹20.58 Cr in 2023-24 and ₹21.29 Cr in 2024-25.

Shareholding Details

The change in ownership structure is detailed in the table below:

Subsidiary Overview

Trident Mediquip Limited operates exclusively in India. The filing confirms that no specific governmental or regulatory approvals were required for this acquisition, nor were there any indicative time periods or cash considerations disclosed for the completion of the private placement. The subsidiary's performance over the last three years reflects a steady upward trajectory in its financial operations.

Hardik Desai Family Trust has increased its shareholding in Trident Lifeline Limited to 7.15% following an open market acquisition of 9,000 shares. The transaction, executed on May 29, 2026, was disclosed to the stock exchange in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The trust, part of the promoter group, now holds a total of 8,53,166 equity shares carrying voting rights.

The acquisition details indicate that the trust's holding prior to the transaction stood at 8,44,166 shares, representing 7.07% of the total share capital. Following the purchase of 9,000 shares, the stake rose to 7.15% of the total voting capital. The total diluted share capital of the target company was reported as Rs. 12,49,34,000, comprising 1,24,93,400 equity shares of Rs. 10 each.

Acquisition Details

The disclosure outlines the specific changes in the shareholding pattern of Hardik Desai Family Trust. The mode of acquisition was the open market, and the shares were acquired on May 29, 2026. The equity share capital of Trident Lifeline Limited remained unchanged at Rs. 11,93,30,000 before and after the transaction, consisting of 1,19,33,000 equity shares of Rs. 10 each.

The disclosure was submitted by Hardik Jigishkumar Desai, the trustee of the Hardik Desai Family Trust and the Ultimate Beneficial Owner (UBO). The confirmation of the filing was recorded on June 1, 2026, in Surat. The shares of Trident Lifeline Limited are listed on BSE Limited with the scrip code 543616.